1. Home
  2. BLRX vs KIRK Comparison

BLRX vs KIRK Comparison

Compare BLRX & KIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • KIRK
  • Stock Information
  • Founded
  • BLRX 2003
  • KIRK 1966
  • Country
  • BLRX Israel
  • KIRK United States
  • Employees
  • BLRX N/A
  • KIRK N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • KIRK Diversified Commercial Services
  • Sector
  • BLRX Health Care
  • KIRK Miscellaneous
  • Exchange
  • BLRX Nasdaq
  • KIRK Nasdaq
  • Market Cap
  • BLRX 17.3M
  • KIRK 20.2M
  • IPO Year
  • BLRX 2011
  • KIRK 2002
  • Fundamental
  • Price
  • BLRX $3.59
  • KIRK $1.46
  • Analyst Decision
  • BLRX Strong Buy
  • KIRK Buy
  • Analyst Count
  • BLRX 2
  • KIRK 2
  • Target Price
  • BLRX $220.00
  • KIRK $4.50
  • AVG Volume (30 Days)
  • BLRX 154.8K
  • KIRK 203.3K
  • Earning Date
  • BLRX 03-25-2025
  • KIRK 03-20-2025
  • Dividend Yield
  • BLRX N/A
  • KIRK N/A
  • EPS Growth
  • BLRX N/A
  • KIRK N/A
  • EPS
  • BLRX N/A
  • KIRK N/A
  • Revenue
  • BLRX $21,991,000.00
  • KIRK $458,411,000.00
  • Revenue This Year
  • BLRX N/A
  • KIRK N/A
  • Revenue Next Year
  • BLRX N/A
  • KIRK $0.37
  • P/E Ratio
  • BLRX N/A
  • KIRK N/A
  • Revenue Growth
  • BLRX N/A
  • KIRK N/A
  • 52 Week Low
  • BLRX $3.20
  • KIRK $1.39
  • 52 Week High
  • BLRX $57.60
  • KIRK $3.00
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 36.94
  • KIRK 37.18
  • Support Level
  • BLRX $3.26
  • KIRK $1.51
  • Resistance Level
  • BLRX $4.17
  • KIRK $1.58
  • Average True Range (ATR)
  • BLRX 0.28
  • KIRK 0.07
  • MACD
  • BLRX 0.24
  • KIRK -0.00
  • Stochastic Oscillator
  • BLRX 36.26
  • KIRK 0.00

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About KIRK Kirkland's Inc. COMMONSTOCK

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

Share on Social Networks: